Back to
Trexquant Investment LP
PTGX
Showing 5 of 19 quarters
Position history for
Trexquant Investment LP's holdings in PROTAGONIST THERAPEUTICS INC
No. Trexquant Investment exited its PTGX (Protagonist Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 36,018 shares worth $2M. Trexquant Investment first reported PTGX in Q1 2020 and held it in 13 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$1M
Total Shares Change
-23,091
Quarter-by-Quarter History